SCHEMBL20111609

SCHEMBL20111609

CN(Cc1ccco1)C(=O)n1ccnc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LIPE Q05469 1/20 0.48
RIPK1 Q13546 1/20 0.48
HSD11B1 P28845 1/20 0.44
ALDH1A1 P00352 5/20 0.43
CYP1A2 P05177 5/20 0.43
HSD17B10 Q99714 4/20 0.43
CYP3A4 P08684 3/20 0.43
CYP2C19 P33261 3/20 0.43
CLK4 Q9HAZ1 3/20 0.43
HIF1A Q16665 1/20 0.43
MAPK1 P28482 1/20 0.42
CYP2D6 P10635 2/20 0.42
ALOX5 P09917 1/20 0.41
HPGD P15428 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.40
RXFP1 Q9HBX9 1/20 0.40
HSP90AA1 P07900 1/20 0.39
ADAM17 P78536 1/20 0.39
TSHR P16473 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3678339 0.79 TSHR (0.43) LIPERIPK1ALDH1A1CYP1A2HSD17B10
SCHEMBL3678342 0.79 TSHR (0.43) LIPERIPK1ALDH1A1CYP1A2HSD17B10
SCHEMBL10916877 0.78 TRPM8 (0.45) ALDH1A1
SCHEMBL10916594 0.78 TSHR (0.41) LIPEALDH1A1CYP1A2CYP3A4CYP2C19
SCHEMBL5648204 0.78 CYP1A2 (0.51) RIPK1CYP1A2CYP3A4CYP2C19CYP2D6
SCHEMBL10338580 0.75 TSHR (0.38) RIPK1ALDH1A1CYP1A2CYP3A4CYP2C19
SCHEMBL1171099 0.73 AHR (0.42) ALDH1A1
SCHEMBL19691848 0.73 ALDH1A1 (0.50) ALDH1A1CYP3A4CYP2D6
SCHEMBL28236735 0.73 ALDH1A1 (0.50) ALDH1A1HSD17B10HPGDNPSR1L3MBTL1
SCHEMBL10396604 0.72 TRPV1 (0.49) ALDH1A1CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10961238-B2 Modulators of hedgehog (Hh) signaling pathway E-THERAPEUTICS PLC (GB) 2021-03-30 US disclosed
US-10961238-B2 Modulators of hedgehog (Hh) signaling pathway E-THERAPEUTICS PLC (GB) 2021-03-30 US disclosed
US-20200055847-A1 MODULATORS OF HEDGEHOG (HH) SIGNALLING PATHWAY E-THERAPEUTICS PLC (GB) 2020-02-20 US disclosed
US-20200055847-A1 MODULATORS OF HEDGEHOG (HH) SIGNALLING PATHWAY E-THERAPEUTICS PLC (GB) 2020-02-20 US disclosed
WO-2018078360-A1 MODULATORS OF HEDGEHOG (HH) SIGNALLING PATHWAY E-THERAPEUTICS PLC (GB) 2018-05-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10961238-B2 Modulators of hedgehog (Hh) signaling pathway SHH, GLI1, SMO LIPE 4474/4885RIPK1 1747/4885HSD11B1 1272/4885
US-20200055847-A1 MODULATORS OF HEDGEHOG (HH) SIGNALLING PATHWAY SHH, GLI1, SMO LIPE 4492/4885RIPK1 1738/4885HSD11B1 1185/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.